Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 175 record(s)

Req # A-2021-00105

In regards to staff housing units that are not owned by Parks Canada, please provide a list containing the asset name and the amount that Parks Canada was invoiced by PSPC and also provide number of days that they are vacant

Organization: Parks Canada

2 page(s)
March 2022

Req # A-2019-00003

•All records concerning or related to the federal government’s Directive on Automated Decision-Making that was prepared by or provided to the PMPRB. (January 1, 2019 to May 2, 2019). •A list of all pending access to information requests at the PMPRB (as of May 2, 2019). •All records relating to the impact of the pending amendments on national pharmacare or the impact of national pharmacare on the pending amendments (From May 2, 2019 to March 1, 2022). •The agenda and minutes for any meetings held by PMPRB executives between January 1, 2018 and May 1, 2019 that concerned the pending amendments. •All revisions or redrafts of the Regulatory Impact Analysis Statement (date of my first request to May 2, 2019). •All records relating to the new basket of countries under the pending amendments, including the inclusion or exclusion of particular countries (date of my first request down to May 2, 2019). •All records relating to the adoption of new pricing factors under the pending amendments (date of my first request down to May 2, 2019). •All records relating to changes in the reporting requirements for patentees under the pending amendments, especially the requirement to report confidential discounts or rebates (date of my first request down to May 2, 2019). •All records relating to a possible decision to distinguish between existing and new medicines in the application of the pending regulations (whether concerning pricing rules, reporting requirements, or any other legal obligation) (date of my first request down to May 2, 2019). •All studies, reports, or other documents prepared by or held by the PMPRB which deal with changes to the content of the pending regulations or the guidelines which are being developed (date of my first request down to May 2, 2019). •All communications regarding the proposed amendments between the PMPRB and one or more of the following organizations: Health Canada, ISED, or CIPO (date of my first request down to May 2, 2019). •All letters or other communications received between September 1, 2018 and May 1, 2019 that question or criticize the pending amendments (date of my first request down to May 2, 2019). •All records generated by the PMPRB or another federal government entity that comment on or analyze the report prepared by Mr. David Dodge (August 23, 2018 to May 2, 2019). •A copy of all training presentations concerning the pending amendments that were held or were supposed to be held between Setptember 1, 2019 and May 1, 2019.

Organization: Patented Medicine Prices Review Board Canada

5557 page(s)
March 2022

Req # A-2022-05127

Copies of all emails to/from Douglas Clark, Melanie Bourassa-Forcier, Tanya Potashnik and Health Canada officials from November 1, 2021 to January 31, 2022.

Organization: Patented Medicine Prices Review Board Canada

20 page(s)
March 2022

Req # A-2021-00011

Request to provide any communications received or sent by the Manager of the Initial Review Unit between April 1, 2019, and June 24, 2021, and which contains the word “white” or “woke”.

Organization: Canadian Human Rights Commission

47 page(s)
October 2021

Req # A-2021-00049

A copy of documents pertaining to the Solicitation No. 5P468-21-0058 regarding Terra Nova National Park Utility Systems Recapitalization Phase 3

Organization: Parks Canada

1 page(s)
October 2021

Req # A-2021-00057

A copy of the bathymetric maps of Marechal and Caribou lakes in La Mauricie National Park, Quebec

Organization: Parks Canada

0 page(s)
October 2021

Req # A-2021-00058

Information regarding date, price and transfer of ownership agreement for Livingston Island in the Big Rideau Lake.

Organization: Parks Canada

24 page(s)
October 2021

Req # A-2021-00062

A copy of briefing note PK2021-00435-United Kingdom-Canada Arctic research collaboration: Parks Canada’s participation

Organization: Parks Canada

5 page(s)
October 2021

Req # A-2021-01071

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Novartis Pharmaceuticals Canada Inc. over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 11, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
October 2021

Req # A-2021-10625

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and AbbVie over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
October 2021
Date modified: